Posts

Showing posts with the label Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market Share

The Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Market Is Experiencing Significant Demand in the Market Owing To the Incidence Rate of the Disease Worldwide

Image
Paroxysmal Nocturnal Hemoglobinuria, or PNH, is an inherited condition that causes the impaired production and premature death of red blood cells, mainly in the legs. The disease affects red blood cells that carry oxygen; platelets, which play a major role in blood clotting; and white blood cells that are necessary for the organism to fight infection. It can cause neurological disorders, including hypertension, impaired consciousness, unconsciousness, fever, decreased blood pressure, increased bleeding flow, and death. As this condition is an inherited disorder, most individuals with this disease do not develop any symptoms until they reach the age of 60 years old. Symptoms commonly occur in individuals who have low plasma volume (less than eighty milligrams per deciliter of blood). However, some individuals with severe conditions may show symptoms even at the normal blood volume. Some of the more common symptoms include fatigue, leg pain, nausea, vomiting, anemia, weakness, blurred vi...